Search

Congenital cytomegalovirus causing deafness in children: an update

Congenital CMV is the leading non-genetic cause of sensorineural hearing loss in children. Keith Trimble draws our attention to this and gives a comprehensive guide on diagnosis and treatment. Congenital cytomegalovirus (cCMV) infection is common, affecting 1% of all newborns,...

History of ESPO

Martin Bailey, Secretary-General of ESPO, narrates the story of a society which has promoted and supported the development of paediatric otolaryngology in Europe. In the early 1950s, pioneers in paediatric otorhinolaryngology became active in European countries such as Poland, Hungary,...

Academic BACO 2015

Putting together the academic programme for BACO is a monumental task. Academic Chairman Shakeel Saeed and Peter Andrews, the Academic Secretary of the conference, tell us how to make it a success. Conference season is nearly upon us, and Liverpool...

The common frontal sinusotomy (Lothrop) and chronic rhinosinusitis

As our understanding of the pathophysiology of CRS evolves, so do our treatment strategies. It is accepted that in many cases, the main role of surgery is to allow better penetration of topical therapies to the sinus cavities. What, then,...

Wound moisture sensing in traumatic wounds

Wounds can be small and unpleasant, or may be large and life-threatening. The skin is a physical and an immunological barrier to infection, and any defect in the integrity of the skin may enable bacterial or fungal invasion. The successful...

Assessment of genetic disorders: congenital sensorineural hearing loss

Severe or profound sensorineural hearing impairment (SNHI) is a common birth defect, affecting approximately 1 in 1000 newborns [1]. SNHI may result from environmental causes or have a genetic basis. The genetic causes can be further subdivided into non-syndromic (isolated...

Access to and uptake of cochlear implants in the UK

Assessing demands on cochlear implant (CI) services is very important for both commissioners and clinicians in anticipating clinical need and funding requirements. Commercial CI’s were introduced in the late 1980s. Initial funding was from charitable sources. The first major advance...

Mapping the financial and disease burden of hearing loss and associated interventions

The prevalence and burden of ear and hearing disorders is huge and, historically, has been underappreciated. Globally, unaddressed hearing loss poses a growing public health challenge, requiring urgent attention from policymakers, health professionals and civil society. The recently published World...